Treatments that can modify the disease course of Alzheimer’s may sadly be several years away, so researchers are looking for current therapies that may have an impact. Secondary analysis of the DOMINO trial (announced in 2012) suggests an off-patent drug may be able to delay the need for Alzheimer’s patients to enter nursing homes. This research is published in The Lancet Neurology.
This briefing at the SMC discussed issues such as:
Roundup comments accompanied this briefing.
Prof. Robert Howard, Professor of Old Age Psychiatry, University College London
Dr Patrick Philips, Senior Statistician, MRC Clinical Trials Unit at University College London